| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326763 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
To summarize, alterations of the DR4 gene do not lead to clinically relevant ovarian cancer predisposition and are therefore most unlikely to contribute to familial ovarian cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Peter Horak, Dietmar Pils, Max Roessler, Sandra Tomek, Katarzyna Elandt, Robert Zeillinger, Christoph Zielinski, Michael Krainer,